Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer. - Wikidata - thesis-toulmin - TriplyDB

Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.

Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.

http://www.wikidata.org/entity/Q37228130

about

Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus

P2860

Q26801345-15514107-39D0-4FD8-9960-4250297CC9EE Q34161592-0857A996-3F62-448D-BCA9-13FE0F2E36FA Q34508850-04A39DFE-BAC4-4E9D-BEF1-44B5BA4D767C

P2860

Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.

http://www.wikidata.org/entity/Q37228130

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@en

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@nl

type

label

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@en

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@nl

prefLabel

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@en

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@nl

P1433

Q37228130-89695929-97F6-41D1-B94C-46C37231144A

P1476

Q37228130-6C0E0145-5971-431E-935A-D1F9434DDA43

P2093

Q37228130-0FDEE003-3E07-4176-B5DE-4A8AA0424303

Q37228130-1CB40498-0594-4A45-B70F-365CB40A7C2D

Q37228130-713CD0C9-5D54-4C2C-9787-D025E59B66BD

Q37228130-89093496-D934-44ED-ABED-B00A8AB422D8

Q37228130-972ABC6C-DE4C-48A3-81E3-34E6BC078162

Q37228130-AD0E46FF-8BDD-4E45-823D-92D7F976D785

Q37228130-B5A29EF3-AE4D-42FC-B6E9-312041BCAEF0

Q37228130-D14E9ECE-7258-4DFC-9C81-4D7960483CE8

Q37228130-F4EA238F-4FA9-4A97-AB60-8FB2E19D3486

Q37228130-F9F28505-2D01-4F52-9835-861BEB53556F

P2860

Q37228130-004C3F4B-C139-4D22-AD32-C3DCD4E9B7C6

Q37228130-07AC854F-7351-483F-8492-64E6BD7774CA

Q37228130-37E0ABBA-BA34-4453-870C-CF1553871115

Q37228130-4B982882-D2EC-4A16-AC31-7D88CCA0968F

Q37228130-4CF85FC1-FD8C-49E4-8EEE-7FA55BD78A3A

Q37228130-4D917D67-7A36-4E08-AFAA-6821CEE9128B

Q37228130-4DCD98A3-A841-4496-AD2B-D8FCDFAE7AA8

Q37228130-4EDC6704-7325-46C3-B840-6B1E9BDB8218

Q37228130-4F345456-430E-454D-95AF-A3C55A7EA7FA

Q37228130-6FAB550F-735D-48B0-AAAC-4B9E902847C1

P304

Q37228130-4C466316-EB19-4584-AC66-E784898FE2BC

P31

Q37228130-E58360D2-D9F5-4DC0-959A-B160C5D76409

P356

Q37228130-9CF76901-D105-4907-8FE1-CDDD17E58239

P407

Q37228130-351CEAD9-817F-47FC-97F7-38C1DF22F60E

P433

Q37228130-724119BD-E31E-412D-943C-C035D5446AE7

P478

Q37228130-41279173-972A-4C9B-A154-51866D822029

P577

Q37228130-3BD18DB1-4237-4E72-BAD7-D06D62A07CDA

P698

Q37228130-F8C42411-22DA-41C1-8A18-CE69DDA97C1E

P932

Q37228130-C3B45B26-CC33-4BD6-95CB-DB72E0509AA5

P356

P1433

P1476

Endoglin promoter hypermethyla ...... man primary esophageal cancer.

@en

P2093

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Ming Dong

http://www.w3.org/2001/XMLSchema#string

Stephen J Meltzer

http://www.w3.org/2001/XMLSchema#string

Xianling Feng

http://www.w3.org/2001/XMLSchema#string

Xiaojing Zhang

http://www.w3.org/2001/XMLSchema#string

Xinmin Fan

http://www.w3.org/2001/XMLSchema#string

Yulan Cheng

http://www.w3.org/2001/XMLSchema#string

Yuriko Mori

http://www.w3.org/2001/XMLSchema#string

Zhe Jin

http://www.w3.org/2001/XMLSchema#string

Zhenfu Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells

Cancer statistics, 2012

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

CpG island methylation and expression of tumour-associated genes in lung carcinoma.

Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.

Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.

Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia.

Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa

P304

3604-3609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28276

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23893879

http://www.w3.org/2001/XMLSchema#string

P932

3796027

http://www.w3.org/2001/XMLSchema#string